Boston Scientific Floats Taxus Base Price; J&J Counters TAXUS IV In Court
Boston Scientific is invoking clinical data from the TAXUS IV trial's diabetic patient subset to thwart Johnson & Johnson's attempt to enjoin U.S. sales of the Express2 and Taxus stents